gip/glp 1-agonist tirzepatide Frontiers Twincretin drug Tirzepatide shows unmatched

This leads to: Excessive muscle loss Fatigue and weakness Hair thinning or shedding (telogen effluvium) Nutrient deficiencies Metabolic slowdown How to prevent this: Track protein intake (minimum 0.7g per pound of body weight daily) Eat protein first at every meal Use protein shakes if whole food feels too filling Dont let the medication be an excuse to skip meals Dehydration: Reduced food intake often means reduced fluid intake

This is why the larger phase 3 and cardiovascular outcomes trials are essential

Track your food intake and physical activity in a structured way

MACE-3, major cardiovascular event (cardiovascular death, nonfatal myocardial infarct, or nonfatal stroke)

Rybelsus [package insert]

Another notable analog is cagrilintide, a long-acting amylin analog optimized for improved stability, receptor binding, and resistance to fibril formation